30
Participants
Start Date
April 30, 2001
Primary Completion Date
December 31, 2007
rituximab
Given IV
cyclophosphamide
Given IV
filgrastim
Given SC
yttrium Y 90 ibritumomab tiuxetan
Given IV
peripheral blood stem cell transplantation
Undergo PBSCT
Johns Hopkins University, Baltimore
National Cancer Institute (NCI)
NIH